BioLife Solutions, Inc. announced that DHI Global Medical Group has adopted BioLife's proprietary HypoThermosol cell/tissue storage and shipping medium to improve ex-vivo survival of hair grafts during transplantation procedures. DHI Global used volumes of HypoThermosol in its offices in Paris, London, and Athens, with a goal of establishing use of HypoThermosol as a standard of care through its network of more than 30 global locations. The International Society of Hair Restoration Surgery (ISHRS) estimates that nearly 300,000 surgical hair restoration procedures were performed worldwide in 2010.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.16 USD | +1.73% |
|
+19.45% | +41.94% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.94% | 1.05B | |
-4.45% | 179B | |
-1.94% | 100B | |
-5.98% | 46.16B | |
+18.16% | 44.81B | |
+10.21% | 44.38B | |
+14.59% | 29.53B | |
+22.31% | 25.83B | |
-5.65% | 23.97B | |
+5.46% | 22.5B |
- Stock Market
- Equities
- BLFS Stock
- News BioLife Solutions, Inc.
- DHI Global Medical Group Adopts BioLife Solutions, Inc.'s HypoThermosol (R) as Improved Hair Graft Storage Medium